1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  6. QuickLinks
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  6. QuickLinks
  1. Launch
  1. My Preqin
Book a demo

Arrakis Therapeutics, Inc.

Have updates for this profile?  Please contribute data

About
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2015

Location

Waltham MA US

Primary Industry

Pharmaceuticals

About

Founded in 2015 and based in Massachusetts, US, Arrakis Therapeutics, Inc. operates as a biopharmaceutical company which engages in the research and development of RNA-targeted small molecules medicine which helps in the treatment of neurologic diseases, cancer and rare genetic diseases.
Current Investors
Canaan Partners, OUP (Osage University Partners), Pfizer Inc.

Request a demo to show more

Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Oncology/Cancer Treatment, Pharmaceutical Research & Development, Specialty Pharmaceuticals
Website
www.arrakistx.com
Company Stage
Series B
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo